DGX peers and competitors
Quest Diagnostics Incorporated · end-of-day data as of Oct 16, 2026
Quest Diagnostics Incorporated
$235.00+3.5%
Buy · 18 analystsPT $233.86 -0.5%
DGX’s peers by industry and size include Thermo Fisher Scientific (TMO), Danaher (DHR) and Agilent Technologies (A). Among these 12 companies DGX ranks 9th by market cap ($25.94B); its P/E of 24.9 compares with a median of 38.4 for its peers.
Peers by industry and size
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $690.00 | -0.9% | -0.9% | -3.3% | 37.1 | $255B | |
| 2 |  | $229.04 | -1.1% | -4.8% | +2.8% | 40.7 | $161B | |
| 3 |  | $172.97 | -1.5% | -1.5% | +0.5% | 34.0 | $48.77B | |
| 4 |  | $560.36 | +2.4% | -26.9% | +34.9% | 39.7 | $44.15B | |
| 5 |  | $266.90 | -1.5% | -3.0% | +3.6% | 33.1 | $43.93B | |
| 6 |  | $436.95 | -1.6% | -1.6% | +4.4% | 109.0 | $42.9B | |
| 7 |  | $262.54 | -2.0% | -10.6% | -16.6% | 49.0 | $39.64B | |
| 8 |  | $1,622.29 | -1.0% | -1.0% | -7.3% | 36.5 | $32.51B | |
| 9 | | $235.00 | -1.7% | -4.7% | -0.5% | 24.9 | $25.94B | |
| 10 |  | $317.95 | -2.2% | -6.1% | +5.8% | 26.3 | $25.79B | |
| 11 |  | $152.64 | -1.3% | -3.0% | -18.2% | 72.7 | $17.03B | |
| 12 |  | $300.15 | -2.0% | -3.4% | +3.1% | — | $14.46B |
Data as of Oct 16, 2026 close.